Topical formulation of a novel drug to treat gout and other inflammatory diseases of the joints.
Parole chiave GEL FORMULATION, GOUT, INFLAMATION
Riferimenti JACEK ADAM TUSZYNSKI
Riferimenti esterni Prof. Maria Fernandes, Laval University, Quebec City, Canada
Prof. Afsaneh Lavasanifar, University of Alberta, Edmonton, Canada
Gruppi di ricerca 28- biomedica
Descrizione A novel small molecule with high potency and specificity for beta VI tubulin has been identified and tested as a potential therapeutic agents for inflammatory diseases such as gout. In this project, we will design and develop a topical transdermal application of this drug candidate in the form of a gel or a cream. The design will be performed in Turin, the actual formulation in Edmonton, Canada and its testing in vivo in Quebec City, Canada with the guidance of our Canadian collaborators.
Conoscenze richieste bioengineering, drug formulation, pharmacokinetics. basic pharmacology
Scadenza validita proposta 01/11/2020 PROPONI LA TUA CANDIDATURA